Literature DB >> 1718239

Galanin immunoreactivity in neuroendocrine tumors.

T Sano1, M E Vrontakis, K Kovacs, S L Asa, H G Friesen.   

Abstract

We investigated immunoreactivity for galanin, a 29-amino acid peptide, in formalin-fixed, paraffin-embedded sections of 123 neuroendocrine tumors. Galanin-immunoreactive cells were found in one of 12 hypothalamic gangliocytomas, nine of 18 adrenal pheochromocytomas, nine of 14 pituitary corticotroph adenomas, and one of two thymic endocrine tumors. In pheochromocytomas, galanin-immunoreactive cells were seen either singly or in clusters. In corticotroph adenomas, many tumor cells were positive for galanin, indicating colocalization of corticotropin and galanin in the same tumor cells. No galanin-immunoreactive cells were noted in four extra-adrenal paragangliomas; 10 medullary carcinomas of the thyroid; 35 endocrine tumors arising in the lung, pancreas, and gastrointestinal tract; and 28 pituitary adenomas composed of cells other than corticotrophs. In nontumorous counterparts of these neuroendocrine tumors, galanin immunoreactivity was observed in nerve cells of the hypothalamus, nerve fibers of the duodenum, and adenohypophyseal cells corresponding to corticotrophs. These findings indicate that galanin expression in neuroendocrine tumors is uncommon and restricted to some tumor types.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718239

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.

Authors:  Ricardo V Lloyd; Constance J D'Amato; Michelle T Thiny; Long Jin; Samuel P Hicks; William F Chandler
Journal:  Endocr Pathol       Date:  1993-06       Impact factor: 3.943

Review 2.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  The Galaninergic System: A Target for Cancer Treatment.

Authors:  Manuel Lisardo Sánchez; Rafael Coveñas
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

4.  Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status.

Authors:  Y Perel; L Amrein; E Dobremez; J Rivel; J Y Daniel; M Landry
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

5.  Galanin System in Human Glioma and Pituitary Adenoma.

Authors:  Sarah Falkenstetter; Julia Leitner; Susanne M Brunner; Tim N Rieder; Barbara Kofler; Serge Weis
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-24       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.